Text Size

Measurement of Lung Water by Transpulmonary Thermodilution in Lung Transplanted Patients (PICCO-LungT)

This study has been completed.
Sponsor:
Information provided by:
Hopital Foch
ClinicalTrials.gov Identifier:
NCT00834054
First received: February 2, 2009
Last updated: July 18, 2011
Last verified: July 2011
History of Changes
  Purpose

Repeated measurements of lung water by single transpulmonary thermodilution during the first postoperative days following lung transplantation


Condition Intervention
Mucoviscidosis
Pulmonary Insufficiency
 Procedure: Double-lung transplantation

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Interest of Repeated Extravascular Lung Water Measurements With the PICCO Device in Lung Transplanted Patients

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Hopital Foch:

Primary Outcome Measures:
  • extra-vascular lung water [ Time Frame: first postoperative days ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • pulmonary permeability index [ Time Frame: first postoperative days ] [ Designated as safety issue: No ]

Estimated Enrollment: 15
Study Start Date: January 2009
Study Completion Date: July 2011
Primary Completion Date: July 2011 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Double-lung transplanted patients Procedure: Double-lung transplantation
Double-lung transplanted patients

  Eligibility

Ages Eligible for Study:   18 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

double-lung transplanted patients

Criteria

Inclusion Criteria:

  • double-lung transplanted patients

Exclusion Criteria:

  • none
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00834054

Locations
France
Hopital Foch
Suresnes, France, 92150
Sponsors and Collaborators
Hopital Foch
Investigators
Study Chair: Charles Cerf, MD Hopital Foch
  More Information

No publications provided

Responsible Party: Hopital Foch
ClinicalTrials.gov Identifier: NCT00834054     History of Changes
Other Study ID Numbers: 2008/18
Study First Received: February 2, 2009
Last Updated: July 18, 2011
Health Authority: France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)

Additional relevant MeSH terms:
Cystic Fibrosis
Pancreatic Diseases
Digestive System Diseases
Lung Diseases
 Respiratory Tract Diseases
Genetic Diseases, Inborn
Infant, Newborn, Diseases

ClinicalTrials.gov processed this record on May 16, 2013